Banque Pictet & Cie’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7M Hold
2,208,280
0.08% 90
2026
Q1
$10.9M Hold
2,208,280
0.08% 99
2025
Q4
$10.3M Hold
2,208,280
0.06% 112
2025
Q3
$10.5M Hold
2,208,280
0.06% 107
2025
Q2
$6.85M Sell
2,208,280
-2,760
-0.1% -$8.23K 0.05% 133
2025
Q1
$7.34M Sell
2,211,040
-32,200
-1% -$113K 0.06% 128
2024
Q4
$7M Hold
2,243,240
0.05% 132
2024
Q3
$8.15M Buy
2,243,240
+46,020
+2% +$187K 0.06% 116
2024
Q2
$10.1M Hold
2,197,220
0.09% 90
2024
Q1
$10.8M Hold
2,197,220
0.1% 82
2023
Q4
$10.3M Sell
2,197,220
-40,120
-2% -$150K 0.09% 87
2023
Q3
$5.71M Buy
2,237,340
+50,000
+2% +$159K 0.07% 135
2023
Q2
$9.8M Hold
2,187,340
0.09% 110
2023
Q1
$10.9M Hold
2,187,340
0.11% 96
2022
Q4
$4.51M Buy
2,187,340
+15,400
+0.7% +$34.6K 0.05% 194
2022
Q3
$5.71M Buy
2,171,940
+24,500
+1% +$85.9K 0.06% 162
2022
Q2
$7.77K Buy
2,147,440
+51,020
+2% +$259K 0.08% 118
2022
Q1
$16.2M Buy
+2,096,420
New +$23.6M 0.13% 87

Other funds holding SOPH

Banque Pictet & Cie's SOPH Position: Q2 2026 in Review

Banque Pictet & Cie held its SOPHiA GENETICS (SOPH) position steady in Q2 2026 at 2,208,280 shares worth $12.7M. The position accounts for 0.08% of the portfolio, ranked #90.

Banque Pictet & Cie first reported a position in SOPH in Q1 2022 and has held it in 18 quarters since. The position peaked at $16.2M in Q1 2022. 28 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Banque Pictet & Cie held 2,208,280 shares of SOPHiA GENETICS worth $12.7M as of Q2 2026.
  • Banque Pictet & Cie left its SOPHiA GENETICS share count unchanged in Q2 2026.
  • SOPHiA GENETICS made up 0.08% of Banque Pictet & Cie's portfolio in Q2 2026, its #90 holding.
  • Banque Pictet & Cie first reported a position in SOPHiA GENETICS in Q1 2022 and has held it in 18 quarters since.
  • Banque Pictet & Cie's SOPHiA GENETICS position peaked at $16.2M in Q1 2022.
  • 28 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.